The Market for Toxicogenomics Products & Services

Researchers in several key markets are exploiting advanced techniques, including DNA microarrays, to assess potentially harmful compounds faster and with greater accuracy than animal testing or in vitro assays. Known as toxicogenomics, this exciting field is transforming how toxicologists think and act. The market implications of this research are especially significant for suppliers to the drug industry where toxicogenomics may be used to reduce misleading toxicity results and streamline drug development. Based on a 38-question survey of over 300 life scientists involved in toxicogenomics, this report provides a look at service providers, informatics products, microarrays and databases from the end-user's perspective. By understanding the actual experiences, preferences and expectations of these researchers, life science suppliers can better position themselves and appeal to the diverse needs of their target market.

The major objectives of this report are as follows:

• Determine the objectives and challenges of toxicology and toxicogenomics studies.
• Identify commonly used toxicology methodologies.
• Determine proportion of researchers who outsource toxicogenomics activities and their vendor selection criteria.
• Assess key elements of toxicogenomics experimental design.
• Estimate current and future toxicogenomics sample throughput.
• Identify preferred suppliers of toxicogenomics products and services.
• Assess level of satisfaction with current toxicogenomics products.
• Ascertain unmet user needs in toxicogenomics product and service market.